Capella 4015 Assessment 5
Student Name
Capella University
NURS-FPX4015 Pathophysiology, Pharmacology, and Physical Assessment: A Holistic Approach to Patient-Centered Care
Prof. Name
Date
Comprehensive Head-To-Toe Assessment
Hello, my name is _. Today, I will conduct a comprehensive head-to-toe physical assessment of Aiyana Tehanata, the patient featured in the Sentinel U case study. She reports tingling in her feet, a pain level of 5 out of 10, and elevated blood sugar levels. This evaluation addresses all key body systems to identify clinical findings relevant to her current condition. I will explain each step and finding aloud to support understanding and patient education throughout the process.
Comprehensive and Professional Assessment
The initial observation shows Aiyana’s fatigued appearance, labored breathing with exertion, and the use of a tripod position. These findings are suggestive of compromised cardiopulmonary function, potentially linked to coronary heart disease (CHD). Her pale skin tone and mild swelling in the lower extremities may reflect venous congestion, often seen in CHD patients (Alevroudis et al., 2024).
Vital Signs and Neurological Status:
| Vital Sign | Finding | Interpretation |
|---|---|---|
| Temperature | 98.4°F | Within normal limits |
| Heart Rate | 96 bpm | Elevated, indicating cardiovascular strain |
| Blood Pressure | 140/88 mmHg | Elevated, consistent with hypertension and CHD |
| Respiratory Rate | 22 breaths/min | Mildly increased, indicative of dyspnea |
| Oxygen Saturation | 94% on room air | Slightly reduced, warrants monitoring |
Neurologically, Aiyana is alert and oriented to person, place, and time. Pupillary reaction is normal, and cranial nerves appear intact. There is no evidence of stroke or TIA, although her speech is slightly slowed, potentially due to cardiovascular effort. Coordination tests such as finger-to-nose are intact.
HEENT and Cardiovascular Findings:
HEENT findings include a normocephalic skull with no deformities. Mild pallor in the sclera may indicate anemia, often associated with CHD (Siddiqui et al., 2022). Hearing and nasal patency are normal. Oral mucosa appears dry, likely due to dehydration, possibly from diuretic use.
Cardiac auscultation reveals an S4 heart sound and an irregular apical pulse, suggesting atrial fibrillation and left ventricular hypertrophy (Pechetty & Nemani, 2020). Peripheral pulses are weak, and symptoms such as tingling feet point to potential peripheral arterial disease (NHLBI, 2024). No jugular venous distension is observed at 45 degrees, and edema is noted without pitting, suggestive of vascular rather than fluid etiology.
Respiratory, Abdominal, Musculoskeletal, and Skin Assessments:
Lung sounds are clear, with no crackles or wheezing. However, her increased respiratory rate and use of orthopnea suggest cardiac-related breathing issues (Mukerji, n.d.).
The abdomen is soft and non-distended. Bowel sounds are present in all quadrants. Mild right upper quadrant tenderness is noted but without signs of liver congestion, hepatomegaly, or ascites.
Muscle strength in the upper and lower extremities is slightly diminished. No joint deformities or contractures are seen. Mild muscle wasting is present, likely related to reduced activity and oxygenation.
Skin assessment shows pale, cool skin and shiny lower extremities, suggestive of chronic edema. Capillary refill is slightly delayed, consistent with peripheral arterial insufficiency (McGuire et al., 2023).
Discussion of Diagnosis and Findings
Aiyana demonstrates clinical signs of CHD, including irregular heart rhythm, elevated blood pressure, and symptoms of peripheral circulatory compromise such as foot tingling. These are compounded by her comorbid conditions, including diabetes and hypertension. Clinical signs suggest her heart is under significant strain, and impaired blood circulation is contributing to neurological symptoms. Medication adjustments and lifestyle interventions are essential for improved cardiac output and reduced symptomatology (Gaudel et al., 2022).
Understanding of Pharmacological Needs
Management of Aiyana’s CHD will involve medications aimed at optimizing heart function and managing comorbid conditions.
| Medication | Purpose | Monitoring/Notes |
|---|---|---|
| Metoprolol | Lowers heart rate and workload | Monitor fatigue; effects stabilize over time (Marti et al., 2020) |
| Lisinopril | Reduces blood pressure, improves perfusion | Watch for dry cough; common side effect |
| Spironolactone | Controls fluid retention and lowers BP | Monitor electrolytes, especially with diabetes |
| Furosemide | Diuretic to reduce fluid overload | Can cause dehydration and electrolyte imbalance |
| Avoid NSAIDs | NSAIDs increase fluid retention | Use alternative analgesics if needed (Bindu et al., 2020) |
Patients should report any dizziness, swelling, or adverse symptoms promptly for clinical reassessment.
Understanding of Pathophysiology
CHD results from plaque buildup (atherosclerosis) in the coronary arteries, limiting oxygen-rich blood delivery to the heart. This leads to angina, arrhythmias, shortness of breath, and eventual myocardial infarction if untreated (Shahjehan & Bhutta, 2024). Diminished cardiac output affects oxygenation throughout the body, which can manifest as fatigue, dizziness, and respiratory distress. Fluid accumulation in the lungs further compromises breathing during physical activity.
Timely symptom recognition and proactive management, including medication, lifestyle modification, and ongoing monitoring, are vital for preventing disease progression and enhancing life quality.
Critical Thinking and Clinical Reasoning
Care Priorities:
| Goal | Strategy |
|---|---|
| Improve Heart Perfusion | Aspirin/Clopidogrel, statins, nitroglycerin, exercise, diet |
| Optimize Cardiac Function | Beta-blockers, ACE inhibitors, monitoring HR/BP |
| Prevent Complications | Monitor labs, consider surgical options, use antiplatelets as needed |
| Educate on Lifestyle Changes | Smoking cessation, low-sodium/low-fat diet, regular physical activity |
Evidence-based recommendations from AHA/ACC support a comprehensive treatment plan combining pharmacology, lifestyle interventions, and diagnostic monitoring for managing CHD effectively (Heidenreich et al., 2022).
Conclusion
This comprehensive head-to-toe assessment identified signs of coronary heart disease in Aiyana Tehanata. Observations revealed both cardiovascular and peripheral concerns, alongside medication implications. A combination of patient-centered care, pharmacological management, and preventive education is key to improving her overall cardiac health and minimizing complications.
References
Alevroudis, I., Kotoulas, S.-C., Tzikas, S., & Vassilikos, V. (2024). Congestion in heart failure: From the secret of a mummy to today’s novel diagnostic and therapeutic approaches: A comprehensive review. Journal of Clinical Medicine, 13(1), 12. https://doi.org/10.3390/jcm13010012
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020). Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical Pharmacology, 180(1), 114147. https://doi.org/10.1016/j.bcp.2020.114147
Capella 4015 Assessment 5
Gaudel, P., Neupane, S., Koivisto, A., Kaunonen, M., & Rantanen, A. (2022). Effects of Intervention on Lifestyle Changes among Coronary Artery Disease Patients: A 6-month Follow-up Study. Nursing Open, 9(4). https://doi.org/10.1002/nop2.1212
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., … & Milano, C. A. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation, 145(18). https://doi.org/10.1161/cir.0000000000001063
Marti, C. N., Fonarow, G. C., Anker, S. D., Yancy, C., Vaduganathan, M., Greene, S. J., … & Butler, J. (2020). Medication dosing for heart failure with reduced ejection fraction — opportunities and challenges. European Journal of Heart Failure, 21(3), 286–296. https://doi.org/10.1002/ejhf.1351
McGuire, D., Gotlib, A., & King, J. (2023). Capillary Refill Time. PubMed Central. https://www.ncbi.nlm.nih.gov/books/NBK557753/
Capella 4015 Assessment 5
Mukerji, V. (n.d.). Dyspnea, Orthopnea, and Paroxysmal Nocturnal Dyspnea. Nih.gov. https://www.ncbi.nlm.nih.gov/books/NBK213/
NHLBI. (2024, October 28). Atherosclerosis – What Is Atherosclerosis? National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/atherosclerosis
Pechetty, R., & Nemani, L. (2020). Additional Heart Sounds—Part 1 (Third and Fourth Heart Sounds). Indian Journal of Cardiovascular Disease in Women WINCARS, 5(02), 155–164. https://doi.org/10.1055/s-0040-1713828
Shahjehan, R. D., & Bhutta, B. S. (2024, October 9). Coronary artery disease. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK564304/
Siddiqui, S. W., Ashok, T., Patni, N., Fatima, M., Lamis, A., & Anne, K. K. (2022). Anemia and heart failure: A narrative review. Cureus, 14(7). https://doi.org/10.7759/cureus.27167